Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

Trav12n-2 Inhibitors

Trav12n-2 inhibitors are a class of chemical compounds designed to specifically target the Trav12n-2 protein or receptor, interfering with its biological function by inhibiting its activity. These inhibitors work by binding to the active site of the Trav12n-2 protein, where they prevent the interaction between the protein and its natural substrate or ligand. By occupying the active site, the inhibitors block the normal biochemical processes in which the Trav12n-2 protein is involved. In some cases, these inhibitors may also act through allosteric mechanisms, binding to regions of the protein distinct from the active site. Allosteric inhibition induces conformational changes that modify the protein's structure, resulting in decreased activity or complete inhibition. The molecular interactions between Trav12n-2 inhibitors and the protein are typically mediated by non-covalent forces such as hydrogen bonding, van der Waals interactions, hydrophobic effects, and ionic interactions, which contribute to the stability and specificity of the inhibitor-protein complex.

The structural diversity of Trav12n-2 inhibitors is a key aspect of their effectiveness. These inhibitors can vary widely in size and complexity, ranging from small organic molecules to larger, more intricate compounds. Common features of these inhibitors include aromatic rings, heterocyclic structures, and various functional groups such as hydroxyl, amine, or carboxyl groups. These functional groups allow the inhibitors to interact with specific residues in the Trav12n-2 protein's binding pockets, forming strong and specific interactions. Additionally, the design of Trav12n-2 inhibitors takes into account important physicochemical properties such as molecular weight, lipophilicity, polarity, and solubility. Hydrophobic regions in the inhibitor structure are designed to interact with non-polar areas of the protein, while polar or charged groups are used to form hydrogen bonds or electrostatic interactions with polar residues. This balance of hydrophilic and hydrophobic properties is crucial for optimizing the inhibitors' binding affinity and ensuring stability in various biological environments, ultimately allowing for precise modulation of Trav12n-2 protein activity.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Phloretin

60-82-2sc-3548
sc-3548A
200 mg
1 g
$64.00
$255.00
13
(1)

Phloretin inhibits the activity of STAT proteins, which may be engaged in the signaling pathways involving Trav12n-2, leading to the functional inhibition of Trav12n-2.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

This chemical inhibits MEK, which is upstream of ERK activation. ERK has been implicated in various signaling pathways, one of which may include Trav12n-2, therefore inhibiting ERK activation can lead to inhibition of Trav12n-2.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 is an inhibitor of PI3K, which is involved in the Akt signaling pathway. The Akt pathway is involved in various cellular processes that could encompass the function of Trav12n-2, thus inhibition of this pathway may result in inhibition of Trav12n-2 activity.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

SP600125 is a JNK inhibitor. By inhibiting JNK, this compound may inhibit downstream signaling processes that involve Trav12n-2, effectively inhibiting Trav12n-2 function.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB203580 is a p38 MAP kinase inhibitor, which would inhibit downstream signaling that could involve Trav12n-2, leading to its functional inhibition.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Wortmannin is a potent PI3K inhibitor, which could inhibit the PI3K/Akt pathway. Since Akt signaling can regulate various proteins, this may include inhibition of Trav12n-2 activity.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

U0126 is an inhibitor of MEK1/2, leading to the inhibition of ERK signaling. As ERK can regulate various cellular functions that may involve Trav12n-2, its inhibition could result in functional inhibition of Trav12n-2.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin inhibits mTOR, which is central to a key signaling pathway for cell growth and proliferation. As mTOR can control the regulation of various proteins, inhibition could lead to decreased function of Trav12n-2.

PP 2

172889-27-9sc-202769
sc-202769A
1 mg
5 mg
$94.00
$227.00
30
(1)

PP2 is an Src family kinase inhibitor. Src kinases can interact with multiple signaling pathways, potentially including those involving Trav12n-2, thereby PP2 may inhibit Trav12n-2 activity.

Erlotinib, Free Base

183321-74-6sc-396113
sc-396113A
sc-396113B
sc-396113C
sc-396113D
500 mg
1 g
5 g
10 g
100 g
$87.00
$135.00
$293.00
$505.00
$3827.00
42
(0)

Erlotinib inhibits the EGFR tyrosine kinase, which can regulate several downstream signaling pathways. This may lead to the inhibition of processes involving Trav12n-2.